Under construction – not a live service
Sign in
Taking people in DenmarkNo phase

Exercise Training to Support Quality of Life During Chemotherapy for Colorectal Cancer

Tests structured exercise in adults with metastatic colorectal cancer starting first-line chemotherapy.

Plain-language title generated from the registry record
Registry title: Randomized Controlled Trial of the Effects of Combined Resistance and AerobiC Exercise on Health-related Quality of Life in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer (REACH)

Key facts

Where
Copenhagen, Herlev, Hillerød, and Roskilde, DenmarkSee the 4 sites

Where in Denmark

  • Centre for Physical Activity Research, Copenhagen Univerisity Hospital - RigshospitaletCopenhagen, DenmarkTaking people
  • Herlev and Gentofte HospitalHerlev, DenmarkTaking people
  • North Zealand University Hospital, HillerødHillerød, DenmarkTaking people
  • Zealand University Hospital, RoskildeRoskilde, DenmarkTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Copenhagen University Hospital, Rigshospitalet
Trial code
NCT06938971
Record updated
13 May 2026
Original description
The primary objective of this trial is to compare the effects of 18 weeks structured exercise training versus on control on healt-related quality of life in patients with mCRC undergoing first-line chemotherapy.Read full original descriptionShow less

Effects of Exercise Training on Health-related Quality of Life in Patients With Unresectable Metastatic Colorectal Cancer: A Multi-center Randomized Controlled Trial

The primary objective of this trial is to compare the effects of 18 weeks structured exercise training versus on control on healt-related quality of life in patients with mCRC undergoing first-line chemotherapy.

Inclusion: Adults (≥18 years of age) schduled to undergo first-line chemotherapy for the treatment of metastatic colorectal cancer.

Exclusion: Pregnancy; A life expectancy of < 6 months; Absolute contraindications to maximal exercise, as per the recommendations by the Danish Society of Cardiology; ECOG (Eastern Cooperative Oncology Group) performance status > 2; Inability to understand the Danish or English language; Engagement in structured moderate-to-high aerobic exercise training for >30 min >1 times/week for the past 3 months at the time of inclusion.

ClinicalTrials.gov NCT06938971